Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Trial of Ixabepilone and Vorinostat in Metastatic Breast Cancer

NCT01084057 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT01084057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01084057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Trial of Ixabepilone and Vorinostat in Metastatic Breast Cancer
Lead sponsor
City of Hope Medical Center
Phase
Phase 1
Overall status
Completed
Start date
May 17, 2010
Completion date
September 27, 2019
Enrollment
56 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

male breast cancer, recurrent breast cancer, stage iv breast cancer